Diabetic cardiac autonomic neuropathy, inflammation and cardiovascular disease.
about
Toxic stress, inflammation and symptomatology of chronic complications in diabetesPathways in the diagnosis and management of diabetic polyneuropathyPredictors of cardiovascular autonomic neuropathy in patients with type 1 diabetes.Cardiac vagal tone, a non-invasive measure of parasympathetic tone, is a clinically relevant tool in Type 1 diabetes mellitus.Resting heart rate variability and exercise capacity in Type 1 diabetes.Cardiac autonomic dysfunction in type 2 diabetes - effect of hyperglycemia and disease duration.Prevalence and correlates of diabetic peripheral neuropathy in a Saudi Arabic population: a cross-sectional study.Diabetes mellitus may induce cardiovascular disease by decreasing neuroplasticity.Male accessory gland inflammation prevalence in type 2 diabetic patients with symptoms possibly reflecting autonomic neuropathy.Diabetic cardiac autonomic neuropathy: Do we have any treatment perspectives?Diabetes, glucose tolerance, and the risk of sudden cardiac deathFactors associated with parasympathetic activation following exercise in patients with rheumatoid arthritis: a cross-sectional studyAutonomic Neuropathy and Endothelial Dysfunction in Patients With Impaired Glucose Tolerance or Type 2 Diabetes MellitusThe metabolic syndrome and neuropathy: therapeutic challenges and opportunities.Safety, pharmacokinetics, and pharmacodynamics of single and multiple luseogliflozin dosing in healthy Japanese males: a randomized, single-blind, placebo-controlled trial.Cardiac Autonomic Neuropathy in Patients with Type 2 Diabetes Mellitus at High Risk for Foot UlcersRelationship between sensorimotor peripheral nerve function and indicators of cardiovascular autonomic function in older adults from the Health, Aging and Body Composition Study.Higher skin autofluorescence in young people with Type 1 diabetes and microvascular complications.Risk factors of diabetic cardiac autonomic neuropathy in patients with type 1 diabetes mellitus: a meta-analysisInflammatory markers are associated with cardiac autonomic dysfunction in recent-onset type 2 diabetes.Clinical evaluation of vasomotor system functionality in type 2 diabetic Patients.Impact of combined exercise training on cardiovascular autonomic control and mortality in diabetic ovariectomized rats.How to Calculate Renyi Entropy from Heart Rate Variability, and Why it Matters for Detecting Cardiac Autonomic Neuropathy.Vitamin D Insufficiency is Associated with Reduced Parasympathetic Nerve Fiber Function in Type 2 Diabetes.Nonblood/urine biomarker of progression of kidney disease in diabetes mellitus.Osteopontin and osteoprotegerin levels in type 2 diabetes and their association with cardiovascular autonomic functionCardiac autonomic neuropathy in patients with diabetes mellitus: current perspectives.Heart rate variability is reduced in acromegaly patients and improved by treatment with somatostatin analogues.Assessment of cardiac autonomic functions by heart rate recovery, heart rate variability and QT dynamicity parameters in patients with acromegaly.Adiponectin, biomarkers of inflammation and changes in cardiac autonomic function: Whitehall II study.The hemodynamic and pain impact of peripheral nerve block versus spinal anesthesia in diabetic patients undergoing diabetic foot surgery.Effect of oral supplementation of composite leaf extract of medicinal plants on biomarkers of oxidative stress in induced diabetic Wistar rats.Cardiac autonomic neuropathy: Risk factors, diagnosis and treatment.Diagnostic Accuracy of Random ECG in Primary Care for Early, Asymptomatic Cardiac Autonomic Neuropathy.Minocycline improves peripheral and autonomic neuropathy in type 2 diabetes: MIND study.The effects of proton pump inhibitors on autonomic tone in patients with erosive and non-erosive esophagitis.Exercise capacity in diabetes mellitus is predicted by activity status and cardiac size rather than cardiac function: a case control study.Cardiac Autonomic Neuropathy as a Result of Mild Hypercaloric Challenge in Absence of Signs of Diabetes: Modulation by Antidiabetic Drugs.Risk factors for cardiopulmonary and respiratory arrest in medical and surgical hospital patients on opioid analgesics and sedatives.High-Intensity Interval Training Is Equivalent to Moderate-Intensity Continuous Training for Short- and Medium-Term Outcomes of Glucose Control, Cardiometabolic Risk, and Microvascular Complication Markers in Men With Type 2 Diabetes
P2860
Q27011633-778EC50A-0CB5-43E9-885C-B2394FB9D776Q28082465-AD64D92E-000A-46ED-8FDC-E12DE0A24254Q33165064-0C4BA5FC-B2D5-4A86-A304-2A008F8B848DQ33455574-CB8016AA-604C-4683-8AF3-9590B71C59A1Q33612347-88DDCB77-53F1-482C-B721-F528B4350A07Q34018512-357B89AD-18FE-4F27-BF79-04495340F189Q34128919-C523181A-189C-43DF-BE78-C7560EE6DE71Q34230667-F48DB86F-13CD-4C5B-A555-4650D5243EE3Q34419004-35F3CC42-4AE1-4412-815F-1A51276E8B9AQ35179226-4311991D-6284-4603-8DDF-962E7B8CEF23Q35932125-75F46EAE-5038-49C8-97A3-A61B5D6A4FF3Q36013882-17999801-78FA-4D1D-8F72-8755E7484183Q37206865-812456E0-AA7C-4FE9-B66C-345DEB873529Q37436781-3A7D7A29-6BAE-4842-AA93-4B11B195EBA7Q37653114-B876218D-8F30-459B-9593-A5C77220C801Q37721941-1C85F5B8-90E3-49C7-B76F-94354ED2414BQ38690952-D41B1B95-4A2A-4DF2-BC12-BD74A0C75547Q38807769-371AE9EC-69BD-4800-A2E0-D25E5F04ABEDQ39008723-64B52A4F-AC45-44CB-BA6B-455AE63301DAQ39535019-A1BF88E4-97DB-4E14-8187-271CE4AACEE4Q41187319-0A57C49B-1653-453A-8A17-96F0738568D1Q41578513-07CA047A-5403-4830-BA7E-CBADFEFE4122Q42054785-E4FADB2A-2578-474E-A90F-53653B9EA1D7Q42279104-C9490D7C-31E5-4E19-BB2C-D0C3F1DA6975Q42362474-06A05EAB-FADF-4252-A0A6-C8A1B087556AQ42379922-CEE7651E-EB93-4651-ABA0-BF5FAD629B7DQ43086883-897B9964-FCF6-4C08-84BC-D582D5277077Q43461564-5A22CC38-3621-4FF6-8156-91730259497AQ43463519-42630ADB-02D0-4DB1-BB68-066886CD5C9BQ47124586-255B4DBB-6883-45F3-959E-B2FB9E5374D7Q47225351-F3B977E0-66EF-4F36-B562-086CAA867EE2Q47281545-772F74CD-F587-4C3D-91C5-118754E67EE7Q47557757-C3BE5743-7758-4404-B657-766264DCB9F6Q47920850-6F8DBEEB-6B34-456D-A6FB-5950E33D3811Q48357574-4966730D-3D2B-4FB3-A3A5-E380491E3333Q50243021-5044117A-5206-40EC-92FB-9947134061C3Q51735896-B39A5517-49C6-4B56-B733-44ADA1893318Q53693594-966CFD2A-2589-4C89-A4B5-00BF6E6A552EQ55243465-94C0154D-929C-475E-BF0C-5835FE9AF1FFQ57091823-F03E0F41-26BC-4744-A33C-CDCFBE558613
P2860
Diabetic cardiac autonomic neuropathy, inflammation and cardiovascular disease.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Diabetic cardiac autonomic neuropathy, inflammation and cardiovascular disease.
@ast
Diabetic cardiac autonomic neuropathy, inflammation and cardiovascular disease.
@en
type
label
Diabetic cardiac autonomic neuropathy, inflammation and cardiovascular disease.
@ast
Diabetic cardiac autonomic neuropathy, inflammation and cardiovascular disease.
@en
prefLabel
Diabetic cardiac autonomic neuropathy, inflammation and cardiovascular disease.
@ast
Diabetic cardiac autonomic neuropathy, inflammation and cardiovascular disease.
@en
P2093
P2860
P356
P1476
Diabetic cardiac autonomic neuropathy, inflammation and cardiovascular disease.
@en
P2093
Aaron I Vinik
Carolina M Casellini
Tomris Erbas
P2860
P356
10.1111/JDI.12042
P577
2013-01-29T00:00:00Z